Quo vadis dPV?

Quo Vadis dPV?

My very personal story
 In 2019 I was surprised by the diagnosis of Parkinson's and anyone who has had this experience knows the feeling of helplessness, panic and uncertainty.

What you need to know about Parkinson's

When a person with Parkinson's or a relative wants to find out about a possible disease, accompanying symptoms play a crucial role. These can affect different parts of the body, including skin, skeleton, sensory organs and psyche. The severity and occurrence of these symptoms vary from person to person, and it is important to note that some symptoms may have other causes.

Parkinson's networks


Due to its complexity, Parkinson's disease represents a challenge that is being addressed in Germany through innovative approaches such as Parkinson's networks. An umbrella company was recently founded that takes on a coordinating role and positions Parkinson's as a model disease for the establishment of networks.

Loneliness as a possible cause of Parkinson's: The importance of support groups

Loneliness and Parkinson's: A possible connection

The idea that loneliness and Parkinson's may be linked is intriguing and sheds new light on the complex causes of this neurodegenerative disease. According to the report in Health, it was found that social isolation and lack of social support could increase the risk of Parkinson's disease. It is thought that the stress and psychological strain associated with loneliness may affect the nervous system and therefore contribute to the development of Parkinson's disease.

New medical guidelines for Parkinson's disease

A new medical guideline on Parkinson's has been available for a few days now.

But what is a medical guideline and how and where is it used?

A medical guideline is a documented procedure for diagnostics and therapy in specific medical areas.

It is based on current scientific findings and clinical experience and serves to ensure and improve the quality of patient care.

Guidelines provide recommendations on how to approach specific diseases or conditions to achieve the best patient outcome.

They are created by professional societies or other medical organizations and are often an important source of information and decision-making aid for doctors and medical staff.

Skin biopsies and DATscan in focus

In recent years, the diagnosis of Parkinson's disease and similar neurodegenerative diseases has made significant progress. New diagnostic procedures such as skin biopsies and DaTscans have attracted the attention of researchers and medical professionals. But when are these tests really necessary, and what can they tell us about Parkinson's? In this article, we will address these questions and examine the role of these innovative diagnostic methods in more detail.

The core message:
The use of skin biopsies and DaTscans to diagnose Parkinson's is not necessary in all cases but should be carefully decided on an individual basis.

Researchers are looking for ways for early Parkinson's therapy - study participants wanted

 Disturbed dream sleep can indicate later Parkinson's disease. Researchers at MHH neurology are now investigating the preliminary phase of the neurodegenerative disease and are offering places for study participants.

New blood test for early detection of Parkinson's disease

Japanese scientists have developed a new blood test that can detect Parkinson's with high accuracy.

The test works by detecting a specific protein called α-synuclein that is misfolded in these diseases.

Previous tests could also detect this protein, but they required an invasive method that involved taking a sample from the spinal cord (cerebrospinal fluid). This new test can detect the protein directly in the blood, making it much easier and less invasive.

Breakthrough in Parkinson's diagnostics

A new method enables the detection of the onset of Parkinson's disease before the onset of brain damage and symptoms such as tremors. A protein in the brain water can indicate early on Parkinson's. Experts describe the method as a "game changer" for the diagnosis, research and treatment of Parkinson's. The findings are expected to have implications for new therapies.

Parkinson's, table tennis and what really matters

Thorsten Boomhuis: You all know that I am also a very ambitious person at the table tennis table. So if I'm going to a world championship, I'll hopefully have a hard time leaving the field to my fellow competitors for a long time to come. That's why my previous posts focused on the sporting competition.

But I always emphasize one thing: the tournaments, including the World Championships, are a means of public relations for PingPongParkinson! It's about becoming better known to those affected by reporting, in order to get even more of them to the table tennis tables.